Xolair 150 mg – S.C Vial

Xolair 150 mg is a biological medication used for the treatment of certain allergic conditions such as chronic allergic asthma and chronic spontaneous urticaria. It contains the active ingredient omalizumab, a monoclonal antibody that works by blocking the activity of IgE antibodies, thereby reducing the body’s allergic response.

Indications:

• Treatment of moderate to severe allergic asthma not controlled by conventional medications

• Treatment of chronic spontaneous urticaria in adults and adolescents

How to Use:

• Administered via subcutaneous injection by a physician or qualified healthcare provider

• Dosage and frequency are determined by the doctor based on patient’s weight and IgE levels

Warnings & Precautions:

• Patients should be monitored after injection for possible severe allergic reactions (anaphylaxis)

• Should only be used under medical supervision

• Use with caution in patients with a history of cardiovascular disease

• Not recommended during pregnancy or breastfeeding unless benefits outweigh risks

Possible Side Effects:

• Headache

• Injection site reactions (redness, swelling, itching)

• Dizziness or fatigue

• Severe allergic reaction (rare)

Storage:

• Store in a refrigerator at 2–8°C

• Do not freeze

• Keep out of reach of children